U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ReFacto
  1. Approved Blood Products

STN: 103779
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: ReFacto
Manufacturer: Genetics Institute, Inc, License #1163
Indication: 

  • Control and prevention of hemorrhagic episodes and for short-term routine and surgical prophylaxis in patients with hemophilia A

Product Information

Supporting Documents

Back to Top